RANGO Registry

International, multicenter, prospective and observational registry. Evaluation of safety and efficacy of angiolite drug eluting stent in non-selected patients from the clinical daily practice.

Device: angiolite

Number of patients: 654

Follow up: 6, 12 and 24- month

Type of lesion: Non-selected, real world population

Clinical events occurred in RANGO registry were very low at 12-months FU. The TLF represent a very low rate showing high efficacy, and ST of 0.61% showed a safety profile comparable with DES current in the market.

Dr A. Pérez de Prado, Hospital and  University of León (León, SPA)

All Clinicals Trials
ANGIOLITE Trial
ANCHOR Trial